Insulin aspart - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge AUST R: 280432Active ingredients:
Insulin aspart
Insulin degludec
Dosage form:
Injection, solution
Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd
Phone:
1800 668 626
|
From
30 Jun 2023
to
05 Jun 2024
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
This shortage is due to manufacturing issues resulting from to an increased global demand for other medicines using the FlexTouch delivery system. The shortage is not due to quality issues. Ryzodeg PENFILL cartridges are available and a Serious Scarcity Substitution Instrument (SSSI) is in force. Please see: https://www.tga.gov.au/safety/shortages/information-about-major-medicine-shortages/about-shortage-ryzodeg-7030-flextouch-insulin-prefilled-pens
|